← Leaderboards
Sanchita P Ghosh
Albert Einstein College Of Medicine, Inc
$1,488,617
Attributed
$4,951,822
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,951,822 · 3
By mechanism
U01$4,951,822 · 3
Top collaborators
- Chandan Guha7 shared
- Shilpa Kulkarni6 shared
- William E Fahl4 shared
- Vidya Kumar4 shared
- Torsten Goesch3 shared
- Peder M Andersen1 shared
- Weng-Lang Yang1 shared
Others in their field
Other Emerging Leaders on “Dose”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$124,321,134
- Beth Baseler · Leidos Biomedical Research, Inc.$52,807,683
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Paula Gonzalez-Maya · Fundacion Inciensa$37,578,679
- Xinhua Li · Nano Terra, Inc.$35,520,438
- Jeffrey Reich · Sparian Biosciences, Inc.$28,575,028
Research focus
DoseCytokineWhole-Body IrradiationOrganC57bl/6 MouseHematopoietic Stem CellsGrowth FactorRadiationLiverBone MarrowExposure ToRadiation ExposureAnimalsIrradiationCellsRadiation InjuriesFemaleRadiation MitigationRecoverySiteMalePlasmaInflammatoryInjury
Grant awards (11)
Thrombopoietin mimetic (TPOm) as a medical countermeasure for GI-ARS$593,823
U01 · FY2025 · AI
Mitigation of Radiation Induced Immune Dysfunction by PrC-210 Treatment$423,626
U01 · FY2025 · AI
Mitigation of Radiation Induced Immune Dysfunction by PrC-210 Treatment$476,834
U01 · FY2024 · AI
Mitigation of Radiation Induced Immune Dysfunction by PrC-210 Treatment$554,945
U01 · FY2023 · AI
Mitigation of Radiation Induced Immune Dysfunction by PrC-210 Treatment$488,484
U01 · FY2022 · AI
Development of thrombopoietin mimetic (TPOm) as a mitigator against Radiation-induced endovascular injuries$460,575
U01 · FY2021 · AI
Development of thrombopoietin mimetic (TPOm) as a mitigator against Radiation-induced endovascular injuries$502,728
U01 · FY2020 · AI
Development of thrombopoietin mimetic (TPOm) as a mitigator against Radiation-induced endovascular injuries$473,599
U01 · FY2019 · AI
Development of thrombopoietin mimetic (TPOm) as a mitigator against Radiation-induced endovascular injuries$353,176
U01 · FY2018 · AI
Development of thrombopoietin mimetic (TPOm) as a mitigator against Radiation-induced endovascular injuries$125,335
U01 · FY2018 · AI
Development of thrombopoietin mimetic (TPOm) as a mitigator against Radiation-induced endovascular injuries$498,697
U01 · FY2017 · AI